Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 9;2:17054. doi: 10.1038/sigtrans.2017.54

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

The change of the spleen size and CD20⁺ B-cell counts in the PB of patients UPNII-09. (a) The whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scans show the larger spleen over the midline of body at 4 months after infusion, then shrink to midline and left midline, respectively, at 12 and 24 months. Especially at 36 months after infusion, the size of spleen become almost normal. (b) The CD20⁺ lymphocyte cells determined by flow cytometry in PB after CART-20 cell infusion is shown. From 1 week after infusion, the proportion began to decline, and it lasted for over 150 weeks.